Stereotactical Photodynamic Therapy With 5-aminolevulinic Acid (Gliolan®)

Updated 06/14/2024

Status Recruiting

Clinical Trial Summary

In this multicenter, randomized, non-blinded trial the efficacy and safety of stereotactical photodynamic therapy with 5-aminolevulinic acid will be investigated in 106 patients with recurrent glioblastoma.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04469699
Study type	Interventional
Source	University Hospital Muenster
Contact	Juliane Schroeteler, Dr. med.
Phone	+491733802878
Email	juliane.schroeteler@ukmuenster.de
Status	Recruiting
Phase	Phase 2
Start date	April 12, 2021
Completion date	April 2026

See also
	Status	Clinical Trial	Phase
	Active, not recruiting	`NCT04762069` - A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma Multiforme	Phase 2
	Recruiting	`NCT04869449` - Neuro-pharmacological Properties of Repurposed Ketoconazole in Glioblastomas	Early Phase 1
	Withdrawn	`NCT03480867` - Pre-operative RT and TMZ in Patients With Newly Diagnosed GBM Diagnosed Glioblastoma. A Phase I Study. (PARADIGMA)	Phase 1
	Not yet recruiting	`NCT05653622` - Simultaneous Integrated Boost FDOPA Positron Emission Tomography (PET) Guided in Patients With Partially- or Non-operated Glioblastoma	Phase 2
	Recruiting	`NCT05954858` - Surgical Tissue Flap to Bypass the Blood Brain Barrier in Glioblastoma	N/A
	Recruiting	`NCT05052957` - hSTAR GBM (Hematopoetic Stem Cell (HPC) Rescue for GBM)	Phase 2
	Recruiting	`NCT05977738` - Repurposed Drugs in Research for Cancer Clinical Trials- Pitavastatin	Early Phase 1
	Recruiting	`NCT04614909` - Study of Pamiparib in Newly Diagnosed and rGBM	Early Phase 1
	Recruiting	`NCT06283927` - The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)
	Recruiting	`NCT06146725` - The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202)
	Recruiting	`NCT06146738` - The PALSUR-study: Palliative Care Versus Surgery in High-grade Glioma Patients (ENCRAM 2203)
	Recruiting	`NCT06118723` - The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)
	Recruiting	`NCT04825275` - Neuro-pharmacological Properties of Repurposed Posaconazole in Glioblastoma: A Phase 0 Clinical Trial	Early Phase 1
	Recruiting	`NCT05333588` - The Safety Study of Autologous TILs Therapy for Patients With Glioblastoma Multiforme.	Early Phase 1
	Recruiting	`NCT05565521` - UNITy-BasED MR-Linac Adaptive Simultaneous Integrated Hypofractionated Boost Trial for High Grade Glioma in the Elderly	Phase 2
	Completed	`NCT05671016` - Brain Imaging to Predict Toxicity in Elderly Patients After Radiotherapy
	Recruiting	`NCT05271240` - Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM	Phase 3
	Recruiting	`NCT05720078` - UNIty-Based MR-Linac Guided Adaptive RadioThErapy for High GraDe Glioma-3 (UNITED-3)	N/A